Literature DB >> 7171971

Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing.

J Doran, J D Hardcastle.   

Abstract

Faecal occult blood testing for 3 consecutive days is recommended for the detection of colorectal cancer. Is this adequate? Haemoccult tests were performed for 6 days on the faeces of 50 patients with colorectal cancer. Enteric-coated aspirin was given during the final 3 days to see if its systemic effect on coagulation would increase tumour bleeding. In 25 patients blood loss was quantified by radiochromium assay. Bleeding was slight and intermittent with large daily fluctuations in individual patients. Median daily loss before aspirin was 1.2 ml and after aspirin 2.5 ml. Thirty per cent of the tumours were Haemoccult negative using the standard 3-day regimen and 18 per cent were negative after aspirin. Over the 6-day period, 10 per cent were persistently negative. We conclude that new methods are required to improve the diagnostic yield from faecal occult blood tests.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7171971     DOI: 10.1002/bjs.1800691209

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

1.  [Conventional and molecular screening (fecal tests)].

Authors:  C Pox; K Schulmann; W Schmiegel
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

2.  Influence of non-steroidal anti-inflammatory drugs in faecal occult blood tests.

Authors:  Y Niv
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

3.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

Review 4.  Early diagnosis of colorectal cancer: a review.

Authors:  J D Hardcastle; N C Armitage
Journal:  J R Soc Med       Date:  1984-08       Impact factor: 5.344

Review 5.  Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 6.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 7.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

8.  Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.

Authors:  J Tibble; G Sigthorsson; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

9.  Improved screening for colorectal cancer by immunological detection of occult blood.

Authors:  D J Frommer; A Kapparis; M K Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-16

10.  Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.

Authors:  A Moran; M Robinson; N Lawson; J Stanley; A F Jones; J D Hardcastle
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.